The global cosmetic peptide manufacturing market value is expected to rise from USD 244.2 million in 2024 to USD 411.9 million by 2034. This estimated growth is expected to be driven by a CAGR of 5.4% ...

The peptide Palmitoyl-GHK (Pal-GHK) has garnered considerable attention in the scientific community due to its structural attributes and potential functional roles in biological research and cellular ...

“Peptides are small chains of amino acids, which are the basic components that make up the proteins found naturally in your ...

The Au-HN-1 nanosystem represents a breakthrough in TSCC treatment, integrating targeted photothermal therapy with advanced ...

The peptide synthesis market is projected to achieve significant growth, with its valuation expected to rise from USD 520.0 ...

A pioneering study has unveiled the Au-HN-1 nanosystem, a cutting-edge approach that promises to transform the diagnosis and ...

Here we explore peptide inhibitors of Cdc20, a substrate-recognition subunit and activator of the E3 ubiquitin ligase the anaphase promoting complex/cyclosome (APC/C) that is essential in mitosis and ...

Under terms of the deal, AbbVie will provide Neomorph with an upfront payment and the potential to earn up to $1.64 billion ...

GLP-1 (glucagon-like peptide-1) discovered in the 1980s functions as a hormone derived from the proglucagon sequence and was found to have a transformative impact on the treatment of diabetes and ...

Creative Peptides, a leading research peptide innovator, announces enhancing its peptide library construction and screening services, which have been upgraded to accelerate drug development across ...

NORTH CHICAGO, Ill. - AbbVie (NYSE: NYSE:ABBV), a global biopharmaceutical company with a market capitalization of $299 billion and annual revenue exceeding $55 billion, has announced the completion ...

AbbVie (NYSE: ABBV) announced today that it has completed its acquisition of Nimble Therapeutics. With the completion of the acquisition, Nimble is now a part of AbbVie.